AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ANTX…

AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

AN2 Therapeutics, Inc.

ANTX · CIK 1880438

4 · Sep 8, 2026 · Director Readnour Robin Shane sold 16.12K shares at $6.04/share ($97,323)

4

Director Readnour Robin Shane sold 16.12K shares at $6.04/share ($97,323)

Filed: Sep 8, 2026
Period: Sep 3, 2026
Accession: 0001193125-26-385511
Filer: AN2 Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov